Global Biological Product Manufacturing Market Research Report 2023

The biological product manufacturing is a complex process which produces products derived from recombinant DNA technology to develop a series of processes to manufacture therapeutic products. A biological product can be a virus, antitoxin, vaccine, blood component or derivative, allergenic product, or analogous product, or any therapeutic serum used for the treatment of a disease in humans. These biological products were developed from multicellular systems comprising of plants, animals, unicellular organisms and a mammalian cell. Biological products are composed of sugars, nucleic acids or combination of both.

The global Biological Product Manufacturing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The biological products are produced in three ways: by developing ways to achieve commercial production of the substance to be used, by gene alteration of the molecule and finally by developing an entirely new substance. Some of the tools used by modern day researcher in the manufacturing of biological products are recombinant DNA and monoclonal antibodies. Recombinant DNA involves altering of the DNA chain of one organism with desired DNA molecule to produce a novel biological product. Monoclonal antibodies were developed from single cell cultures using cloning techniques; these were designed to fight against toxins, viruses, and cancer cells. The first genetically engineered biological product approved for use in the U.S. was a vaccine for hepatitis-B which was approved in 1986, in the same year, other biological products like therapeutic monoclonal antibodies (MAB’s) and alpha interferon’s were approved.

This report aims to provide a comprehensive presentation of the global market for Biological Product Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Product Manufacturing.

The Biological Product Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biological Product Manufacturing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biological Product Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biological Product Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Monoclonal Antibodies

1.2.3 Recombinant Proteins

1.2.4 Growth Hormones

1.2.5 Beta Interferon

1.2.6 Therapeutic Enzymes

1.3 Market by Application

1.3.1 Global Biological Product Manufacturing Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Specialized Clinics

1.3.4 Government Research Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Biological Product Manufacturing Market Perspective (2018-2029)

2.2 Biological Product Manufacturing Growth Trends by Region

2.2.1 Global Biological Product Manufacturing Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Biological Product Manufacturing Historic Market Size by Region (2018-2023)

2.2.3 Biological Product Manufacturing Forecasted Market Size by Region (2024-2029)

2.3 Biological Product Manufacturing Market Dynamics

2.3.1 Biological Product Manufacturing Industry Trends

2.3.2 Biological Product Manufacturing Market Drivers

2.3.3 Biological Product Manufacturing Market Challenges

2.3.4 Biological Product Manufacturing Market Restraints

3.1 Global Top Biological Product Manufacturing Players by Revenue

3.1.1 Global Top Biological Product Manufacturing Players by Revenue (2018-2023)

3.1.2 Global Biological Product Manufacturing Revenue Market Share by Players (2018-2023)

3.2 Global Biological Product Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biological Product Manufacturing Revenue

3.4 Global Biological Product Manufacturing Market Concentration Ratio

3.4.1 Global Biological Product Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biological Product Manufacturing Revenue in 2022

3.5 Biological Product Manufacturing Key Players Head office and Area Served

3.6 Key Players Biological Product Manufacturing Product Solution and Service

3.7 Date of Enter into Biological Product Manufacturing Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Biological Product Manufacturing Historic Market Size by Type (2018-2023)

4.2 Global Biological Product Manufacturing Forecasted Market Size by Type (2024-2029)

5.1 Global Biological Product Manufacturing Historic Market Size by Application (2018-2023)

5.2 Global Biological Product Manufacturing Forecasted Market Size by Application (2024-2029)

6.1 North America Biological Product Manufacturing Market Size (2018-2029)

6.2 North America Biological Product Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Biological Product Manufacturing Market Size by Country (2018-2023)

6.4 North America Biological Product Manufacturing Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Biological Product Manufacturing Market Size (2018-2029)

7.2 Europe Biological Product Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Biological Product Manufacturing Market Size by Country (2018-2023)

7.4 Europe Biological Product Manufacturing Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Biological Product Manufacturing Market Size (2018-2029)

8.2 Asia-Pacific Biological Product Manufacturing Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Biological Product Manufacturing Market Size by Region (2018-2023)

8.4 Asia-Pacific Biological Product Manufacturing Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Biological Product Manufacturing Market Size (2018-2029)

9.2 Latin America Biological Product Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Biological Product Manufacturing Market Size by Country (2018-2023)

9.4 Latin America Biological Product Manufacturing Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Biological Product Manufacturing Market Size (2018-2029)

10.2 Middle East & Africa Biological Product Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Biological Product Manufacturing Market Size by Country (2018-2023)

10.4 Middle East & Africa Biological Product Manufacturing Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Novartis

11.1.1 Novartis Company Detail

11.1.2 Novartis Business Overview

11.1.3 Novartis Biological Product Manufacturing Introduction

11.1.4 Novartis Revenue in Biological Product Manufacturing Business (2018-2023)

11.1.5 Novartis Recent Development

11.2 F.Hoffmann-La Roche

11.2.1 F.Hoffmann-La Roche Company Detail

11.2.2 F.Hoffmann-La Roche Business Overview

11.2.3 F.Hoffmann-La Roche Biological Product Manufacturing Introduction

11.2.4 F.Hoffmann-La Roche Revenue in Biological Product Manufacturing Business (2018-2023)

11.2.5 F.Hoffmann-La Roche Recent Development

11.3 Merck

11.3.1 Merck Company Detail

11.3.2 Merck Business Overview

11.3.3 Merck Biological Product Manufacturing Introduction

11.3.4 Merck Revenue in Biological Product Manufacturing Business (2018-2023)

11.3.5 Merck Recent Development

11.4 Bayer

11.4.1 Bayer Company Detail

11.4.2 Bayer Business Overview

11.4.3 Bayer Biological Product Manufacturing Introduction

11.4.4 Bayer Revenue in Biological Product Manufacturing Business (2018-2023)

11.4.5 Bayer Recent Development

11.5 Lonza

11.5.1 Lonza Company Detail

11.5.2 Lonza Business Overview

11.5.3 Lonza Biological Product Manufacturing Introduction

11.5.4 Lonza Revenue in Biological Product Manufacturing Business (2018-2023)

11.5.5 Lonza Recent Development

11.6 China Biologic Products

11.6.1 China Biologic Products Company Detail

11.6.2 China Biologic Products Business Overview

11.6.3 China Biologic Products Biological Product Manufacturing Introduction

11.6.4 China Biologic Products Revenue in Biological Product Manufacturing Business (2018-2023)

11.6.5 China Biologic Products Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Detail

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Biological Product Manufacturing Introduction

11.7.4 Pfizer Revenue in Biological Product Manufacturing Business (2018-2023)

11.7.5 Pfizer Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Detail

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Biological Product Manufacturing Introduction

11.8.4 Sanofi Revenue in Biological Product Manufacturing Business (2018-2023)

11.8.5 Sanofi Recent Development

11.9 Teva Pharmaceutical Industries

11.9.1 Teva Pharmaceutical Industries Company Detail

11.9.2 Teva Pharmaceutical Industries Business Overview

11.9.3 Teva Pharmaceutical Industries Biological Product Manufacturing Introduction

11.9.4 Teva Pharmaceutical Industries Revenue in Biological Product Manufacturing Business (2018-2023)

11.9.5 Teva Pharmaceutical Industries Recent Development

11.10 Amgen

11.10.1 Amgen Company Detail

11.10.2 Amgen Business Overview

11.10.3 Amgen Biological Product Manufacturing Introduction

11.10.4 Amgen Revenue in Biological Product Manufacturing Business (2018-2023)

11.10.5 Amgen Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Biological Product Manufacturing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Monoclonal Antibodies

    Table 3. Key Players of Recombinant Proteins

    Table 4. Key Players of Growth Hormones

    Table 5. Key Players of Beta Interferon

    Table 6. Key Players of Therapeutic Enzymes

    Table 7. Global Biological Product Manufacturing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Biological Product Manufacturing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Biological Product Manufacturing Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Biological Product Manufacturing Market Share by Region (2018-2023)

    Table 11. Global Biological Product Manufacturing Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Biological Product Manufacturing Market Share by Region (2024-2029)

    Table 13. Biological Product Manufacturing Market Trends

    Table 14. Biological Product Manufacturing Market Drivers

    Table 15. Biological Product Manufacturing Market Challenges

    Table 16. Biological Product Manufacturing Market Restraints

    Table 17. Global Biological Product Manufacturing Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Biological Product Manufacturing Market Share by Players (2018-2023)

    Table 19. Global Top Biological Product Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Product Manufacturing as of 2022)

    Table 20. Ranking of Global Top Biological Product Manufacturing Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Biological Product Manufacturing Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Biological Product Manufacturing Product Solution and Service

    Table 24. Date of Enter into Biological Product Manufacturing Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Biological Product Manufacturing Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Biological Product Manufacturing Revenue Market Share by Type (2018-2023)

    Table 28. Global Biological Product Manufacturing Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Biological Product Manufacturing Revenue Market Share by Type (2024-2029)

    Table 30. Global Biological Product Manufacturing Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Biological Product Manufacturing Revenue Market Share by Application (2018-2023)

    Table 32. Global Biological Product Manufacturing Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Biological Product Manufacturing Revenue Market Share by Application (2024-2029)

    Table 34. North America Biological Product Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Biological Product Manufacturing Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Biological Product Manufacturing Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Biological Product Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Biological Product Manufacturing Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Biological Product Manufacturing Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Biological Product Manufacturing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Biological Product Manufacturing Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Biological Product Manufacturing Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Biological Product Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Biological Product Manufacturing Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Biological Product Manufacturing Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Biological Product Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Biological Product Manufacturing Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Biological Product Manufacturing Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Novartis Company Detail

    Table 50. Novartis Business Overview

    Table 51. Novartis Biological Product Manufacturing Product

    Table 52. Novartis Revenue in Biological Product Manufacturing Business (2018-2023) & (US$ Million)

    Table 53. Novartis Recent Development

    Table 54. F.Hoffmann-La Roche Company Detail

    Table 55. F.Hoffmann-La Roche Business Overview

    Table 56. F.Hoffmann-La Roche Biological Product Manufacturing Product

    Table 57. F.Hoffmann-La Roche Revenue in Biological Product Manufacturing Business (2018-2023) & (US$ Million)

    Table 58. F.Hoffmann-La Roche Recent Development

    Table 59. Merck Company Detail

    Table 60. Merck Business Overview

    Table 61. Merck Biological Product Manufacturing Product

    Table 62. Merck Revenue in Biological Product Manufacturing Business (2018-2023) & (US$ Million)

    Table 63. Merck Recent Development

    Table 64. Bayer Company Detail

    Table 65. Bayer Business Overview

    Table 66. Bayer Biological Product Manufacturing Product

    Table 67. Bayer Revenue in Biological Product Manufacturing Business (2018-2023) & (US$ Million)

    Table 68. Bayer Recent Development

    Table 69. Lonza Company Detail

    Table 70. Lonza Business Overview

    Table 71. Lonza Biological Product Manufacturing Product

    Table 72. Lonza Revenue in Biological Product Manufacturing Business (2018-2023) & (US$ Million)

    Table 73. Lonza Recent Development

    Table 74. China Biologic Products Company Detail

    Table 75. China Biologic Products Business Overview

    Table 76. China Biologic Products Biological Product Manufacturing Product

    Table 77. China Biologic Products Revenue in Biological Product Manufacturing Business (2018-2023) & (US$ Million)

    Table 78. China Biologic Products Recent Development

    Table 79. Pfizer Company Detail

    Table 80. Pfizer Business Overview

    Table 81. Pfizer Biological Product Manufacturing Product

    Table 82. Pfizer Revenue in Biological Product Manufacturing Business (2018-2023) & (US$ Million)

    Table 83. Pfizer Recent Development

    Table 84. Sanofi Company Detail

    Table 85. Sanofi Business Overview

    Table 86. Sanofi Biological Product Manufacturing Product

    Table 87. Sanofi Revenue in Biological Product Manufacturing Business (2018-2023) & (US$ Million)

    Table 88. Sanofi Recent Development

    Table 89. Teva Pharmaceutical Industries Company Detail

    Table 90. Teva Pharmaceutical Industries Business Overview

    Table 91. Teva Pharmaceutical Industries Biological Product Manufacturing Product

    Table 92. Teva Pharmaceutical Industries Revenue in Biological Product Manufacturing Business (2018-2023) & (US$ Million)

    Table 93. Teva Pharmaceutical Industries Recent Development

    Table 94. Amgen Company Detail

    Table 95. Amgen Business Overview

    Table 96. Amgen Biological Product Manufacturing Product

    Table 97. Amgen Revenue in Biological Product Manufacturing Business (2018-2023) & (US$ Million)

    Table 98. Amgen Recent Development

    Table 99. Research Programs/Design for This Report

    Table 100. Key Data Information from Secondary Sources

    Table 101. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Biological Product Manufacturing Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Biological Product Manufacturing Market Share by Type: 2022 VS 2029

    Figure 3. Monoclonal Antibodies Features

    Figure 4. Recombinant Proteins Features

    Figure 5. Growth Hormones Features

    Figure 6. Beta Interferon Features

    Figure 7. Therapeutic Enzymes Features

    Figure 8. Global Biological Product Manufacturing Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Biological Product Manufacturing Market Share by Application: 2022 VS 2029

    Figure 10. Hospitals Case Studies

    Figure 11. Specialized Clinics Case Studies

    Figure 12. Government Research Institutes Case Studies

    Figure 13. Biological Product Manufacturing Report Years Considered

    Figure 14. Global Biological Product Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Biological Product Manufacturing Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Biological Product Manufacturing Market Share by Region: 2022 VS 2029

    Figure 17. Global Biological Product Manufacturing Market Share by Players in 2022

    Figure 18. Global Top Biological Product Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Product Manufacturing as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Biological Product Manufacturing Revenue in 2022

    Figure 20. North America Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Biological Product Manufacturing Market Share by Country (2018-2029)

    Figure 22. United States Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Biological Product Manufacturing Market Share by Country (2018-2029)

    Figure 26. Germany Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Biological Product Manufacturing Market Share by Region (2018-2029)

    Figure 34. China Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Biological Product Manufacturing Market Share by Country (2018-2029)

    Figure 42. Mexico Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Biological Product Manufacturing Market Share by Country (2018-2029)

    Figure 46. Turkey Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Biological Product Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Novartis Revenue Growth Rate in Biological Product Manufacturing Business (2018-2023)

    Figure 49. F.Hoffmann-La Roche Revenue Growth Rate in Biological Product Manufacturing Business (2018-2023)

    Figure 50. Merck Revenue Growth Rate in Biological Product Manufacturing Business (2018-2023)

    Figure 51. Bayer Revenue Growth Rate in Biological Product Manufacturing Business (2018-2023)

    Figure 52. Lonza Revenue Growth Rate in Biological Product Manufacturing Business (2018-2023)

    Figure 53. China Biologic Products Revenue Growth Rate in Biological Product Manufacturing Business (2018-2023)

    Figure 54. Pfizer Revenue Growth Rate in Biological Product Manufacturing Business (2018-2023)

    Figure 55. Sanofi Revenue Growth Rate in Biological Product Manufacturing Business (2018-2023)

    Figure 56. Teva Pharmaceutical Industries Revenue Growth Rate in Biological Product Manufacturing Business (2018-2023)

    Figure 57. Amgen Revenue Growth Rate in Biological Product Manufacturing Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed